Drugs / Fluarix/Influsplit SSW 2012-2013
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01607112 | Jul 2012 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluarix/Influsplit SSW 2012-2013 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01607112 ↗ |
| Modality | Vaccine | “GSK Biologicals' trivalent influenza vaccine manufactured for the 2012/2013 influenza season” NCT01607112 ↗ |
| Route | Intramuscular | “administered intramuscularly (or deeply subcutaneously) in the deltoid region of the non-dominant arm” NCT01607112 ↗ |
| Route | Subcutaneous | “administered intramuscularly (or deeply subcutaneously) in the deltoid region of the non-dominant arm” NCT01607112 ↗ |